146 related articles for article (PubMed ID: 17762961)
1. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression correlates with membrane-type-1 matrix metalloproteinase expression in colorectal cancer tissue.
Guo H; Tatsuguchi A; Shinji S; Fujimori S; Tanaka S; Gudis K; Sugisaki Y; Furukawa K; Tajiri T; Fukuda Y; Kishida T; Sakamoto C
Dis Colon Rectum; 2006 Aug; 49(8):1184-92. PubMed ID: 16752205
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A
APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
6. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of cyclooxygenase 2 and Bcl-2 for cervical lymph node metastasis in mucoepidermoid carcinoma.
Zyada MM; Grawish ME; Elsabaa HM
Ann Diagn Pathol; 2009 Oct; 13(5):313-21. PubMed ID: 19751908
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
Choi HJ; Kim HJ; Choi JH
Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
[TBL] [Abstract][Full Text] [Related]
9. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas.
Pisano C; Ottaiano A; Tatangelo F; Di Bonito M; Falanga M; Iaffaioli VR; Botti G; Pignata S; Acquaviva AM
Anticancer Res; 2005; 25(3B):2065-8. PubMed ID: 16158946
[TBL] [Abstract][Full Text] [Related]
11. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
12. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
[TBL] [Abstract][Full Text] [Related]
13. FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.
Mimori K; Ishii H; Nagahara H; Sudo T; Yamashita K; Inoue H; Barnard GF; Mori M
Cancer Res; 2006 Mar; 66(5):2683-90. PubMed ID: 16510588
[TBL] [Abstract][Full Text] [Related]
14. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
Nakamoto RH; Uetake H; Iida S; Kolev YV; Soumaoro LT; Takagi Y; Yasuno M; Sugihara K
Jpn J Clin Oncol; 2007 Sep; 37(9):679-85. PubMed ID: 17846040
[TBL] [Abstract][Full Text] [Related]
15. Colorectal carcinoma: a retrospective, descriptive study of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001 as observed in Tehran University.
Fazeli MS; Adel MG; Lebaschi AH
Dis Colon Rectum; 2007 Jul; 50(7):990-5. PubMed ID: 17525859
[TBL] [Abstract][Full Text] [Related]
16. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.
Ohd JF; Nielsen CK; Campbell J; Landberg G; Löfberg H; Sjölander A
Gastroenterology; 2003 Jan; 124(1):57-70. PubMed ID: 12512030
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of cyclooxygenase-2 in the prediction of liver metastasis of colorectal carcinoma].
Lu XY; Xu JM; Zhong YS; Ren L; Lai YH; Qin XY
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):54-7. PubMed ID: 17403293
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]